24
The particle size is measured according to the provisions of the EN13544-1:2007 “Respiratory therapy
equipment - Part 1: Nebulising systems and their components”, Annex CC.3 using the multistage
cascade impactor method.
Particle Size:
*MMAD 4.2 µm
MMAD = Mass Median Aerodynamic Diameter
Medication Container Capacity:
7 ml maximum
Sound:
Less than 20 dB
Nebulisation rate:
**Greater than 0.25 ml/min (by weight loss)
Aerosol Output:
*0.69 ml (2ml, 1%NaF)
Aerosol Output Rate:
*0.087 ml/min (2ml, 1%NaF)
Notes:
• The distribution of particle size and aerosol output are measured with 2.5% NaF solution. The particle size
distribution and aerosol output may vary by combination of product, medication and ambient conditions such
as temperature, humidity and atmospheric pressure.
• Performance may vary with drugs such as suspensions or high viscosity. See drug supplier’s data sheet for
further details.
• See web site of OMRON HEALTHCARE EUROPE to update technical information.
URL: www.omron-healthcare.com
* Independently measured at SolAero Ltd., Canada, Dr. John Dennis, according to EN13544-1:2007.
** The Nebulisation rate is measured with saline 0.9% solution at 23°C and can vary with medication and
ambient conditions.
Cumulative % particle mass of sodium fluoride under size
0
10
20
30
40
50
60
70
80
90
100
0010111.0
Particle Size Dp (μm)
Cumulative Undersize %
Individual
Mean
MMAD 4.2 μm
Technical data
